Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial

Table 2 Count data

Number of (a) first and (b) recurrent events of the primary composite endpoint, treatment failure, and its 3 exclusive subcomponents: treatment intensification, step-up in hospital care (comprised of transfer to the ICU and hospital readmissions) and mortality prior to hospital discharge (day X, median: 6 [Q1-Q3 interquartile range: 4–8] days), within 90 and 270 days
day x, day of discharge, at the investigator’s discretion; day 90, end of intervention; day 270, end of follow-up
Abbreviations: ICU Intensive care unit

ISSN: 1465-993X